Evidence map›Paper›PMID 41036144›Full record

ArticleFrontiers in endocrinology2025

Case Report: Management of multiple brown tumors after kidney transplantation.

Qingyi Sun, Yafei Bai, Ruman Chen, Hong Li

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qingyi SunBlood Purification Center, Hainan General Hospital/Hainan Medical University Affiliated Hainan Hospital, Haikou, Hainan, China.
Yafei BaiBlood Purification Center, Hainan General Hospital/Hainan Medical University Affiliated Hainan Hospital, Haikou, Hainan, China.
Ruman ChenBlood Purification Center, Hainan General Hospital/Hainan Medical University Affiliated Hainan Hospital, Haikou, Hainan, China.
Hong LiBlood Purification Center, Hainan General Hospital/Hainan Medical University Affiliated Hainan Hospital, Haikou, Hainan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brown tumor is usually caused by primary or secondary hyperparathyroidism but is exceptionally rare after kidney transplantation. Their rarity and atypical pathological features make diagnosis and treatment particularly challenging. We present a case of a 38-year-old woman with multiple brown tumors secondary to persistent hyperparathyroidism following kidney transplantation. The patient was initially admitted to the orthopedic department for left shoulder dislocation and lytic lesions in the left humerus and was diagnosed with a giant cell tumor of bone. Further investigations revealed elevated parathyroid hormone (PTH) levels and multiple lytic bone lesions throughout the skeleton. Based on these findings, the patient was ultimately diagnosed with multiple brown tumors. As a result, the patient underwent total parathyroidectomy and autotransplantation of parathyroid tissue. Follow-up evaluations showed decreased PTH levels and alkaline phosphatase levels, with improvement in skeletal changes. This case report shares the experience and lessons in managing hyperparathyroidism, both before and after kidney transplantation, emphasizing the importance of clinicians' awareness of the disease and multidisciplinary collaborative management.

Indexed as

Bone NeoplasmsGiant Cell Tumor of BoneHyperparathyroidism, SecondaryKidney TransplantationAdultFemaleHumansParathyroidectomybrown tumorscase reportkidney transplantationparathyroid hormonesecondary hyperparathyroidism

Identifiers

PMID41036144
PMCPMC12479324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.